about
Structure of a DNA Repair Substrate Containing an Alkyl Interstrand Cross-Link at 1.65 Å Resolution † , ‡Sigmoid dose using 3D imaging in cervical-cancer brachytherapy.The association of rectal equivalent dose in 2 Gy fractions (EQD2) to late rectal toxicity in locally advanced cervical cancer patients who were evaluated by rectosigmoidoscopy in Faculty of Medicine, Chiang Mai University.Improving chemoradiotherapy with nanoparticle therapeutics.Patient preferences for side effects associated with cervical cancer treatmentRevival of the abandoned therapeutic wortmannin by nanoparticle drug delivery.FePt nanoparticles as a potential X-ray activated chemotherapy agent for HeLa cells.Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery.Nanomedicine in chemoradiation.Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer.Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles.Direct visualization and quantification of the anticancer agent, cis-diamminedichloro-platinum(II), in human lung cancer cells using in-air microparticle-induced X-ray emission analysis.Patient's specific integration of OAR doses (D2 cc) from EBRT and 3D image-guided brachytherapy for cervical cancer.In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.Synergistic effects of cisplatin-caffeic acid induces apoptosis in human cervical cancer cells via the mitochondrial pathways.
P2860
Q27644183-2AFF86DC-3A35-4E63-87E2-D3782076B1F9Q33840842-6F5F9552-BD04-4EBD-B9B0-23CA8C009C3AQ33923024-06FAEEB8-6537-42A3-975B-DA447C2C8286Q34564219-14B48A3F-271A-4687-95B2-89150A07865AQ34871388-49CE426B-800A-4784-9E86-91BF530007C1Q35991577-502FA95D-63B1-48FE-86DB-25BEEA6E6C04Q36239958-F0DDE1C5-3C85-4495-964E-FE0DE7EED823Q36331546-7DD13122-E730-41D5-9E9F-281FE21E9448Q36838995-8531C88A-51CB-4F05-9C69-AF0C3F0FC88DQ37113921-63770770-04BE-4F4F-BEF9-31AD84521763Q37188521-32235858-1F50-43FE-8C47-1C7FF62D4264Q40009849-C683A4EF-0EFF-4E71-90ED-9BB69A1D9674Q49930505-DA0D0CF2-4361-43FE-A98A-FB6535423B7BQ50914810-EB135240-01AA-4EC3-BE35-82D39BCD3B3FQ54219811-55B889DC-85C7-49B7-95AC-90E9FAA6DFA0
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Chemoradiotherapy in the treatment of cervical cancer.
@en
Chemoradiotherapy in the treatment of cervical cancer.
@nl
type
label
Chemoradiotherapy in the treatment of cervical cancer.
@en
Chemoradiotherapy in the treatment of cervical cancer.
@nl
prefLabel
Chemoradiotherapy in the treatment of cervical cancer.
@en
Chemoradiotherapy in the treatment of cervical cancer.
@nl
P1476
Chemoradiotherapy in the treatment of cervical cancer.
@en
P2093
Patricia J Eifel
P304
P356
10.1016/J.SEMRADONC.2006.02.007
P577
2006-07-01T00:00:00Z